BioSpace News Archive

Business

Sunesis Pharmaceuticals Reports First Quarter 2020 Financial Results and Recent HighlightsSunesis to Host Conference Call Today at 4:30 PM Eastern Time

Sunesis Pharmaceuticals, Inc. reported financial results for the first quarter ended March 31, 2020.

May 7, 2020
·
7 min read
Business

ICU Medical, Inc. Announces First Quarter 2020 Results and Updates Fiscal Year 2020 Guidance

ICU Medical, Inc., a leader in the development, manufacture and sale of innovative medical products used in infusion therapy and critical care applications, announced financial results for the quarter ended March 31, 2020.

May 7, 2020
·
12 min read
Business

Aclaris Therapeutics Reports First Quarter 2020 Financial Results and Provides R&D and Business Highlights

Aclaris Therapeutics, Inc., a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, announced its financial results for the first quarter of 2020 and provided research and development and business highlights.

May 7, 2020
·
9 min read
Business

Calithera Biosciences Reports First Quarter 2020 Financial Results and Recent Highlights

Calithera Biosciences, Inc., a clinical-stage biotechnology company focused on discovering and developing novel, small-molecule drugs for the treatment of cancer and other life-threatening diseases, announced its financial results for the first quarter ended March 31, 2020.

May 7, 2020
·
8 min read
Business

Caladrius Biosciences Provides Corporate Update and Reports 2020 First Quarter Financial Results

Company initiates development of CLBS119 for the repair of COVID-19 induced lung damage and expands its proprietary CD34+ cell therapy portfolio

May 7, 2020
·
12 min read
Business

Trevi Therapeutics Announces First Quarter 2020 Financial Results and Corporate Update

Trevi Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of nalbuphine ER to treat serious neurologically mediated conditions, announced financial results for the quarter ended March 31, 2020, as well as recent business highlights.

May 7, 2020
·
7 min read
Business

Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial Results; Updates Full Year 2020 Outlook

Helius Medical Technologies, Inc., a neurotech company focused on neurological wellness, reported financial results for the quarter ended March 31, 2020.

May 7, 2020
·
12 min read
Business

Optinose Reports First Quarter 2020 Financial Results and Operational Updates

Optinose, a pharmaceutical company focused on patients treated by ear, nose and throat and allergy specialists, reported financial results for the quarter ended March 31, 2020, and provided operational updates.

May 7, 2020
·
9 min read
Deals

The Conatus Pharmaceuticals Special Meeting of Stockholders Seeking Approval for Proposed Merger with Histogen Inc. will Reconvene on May 21, 2020

Conatus Pharmaceuticals Inc. convened and adjourned its special meeting of stockholders in order to obtain a quorum and specific stockholder approvals required pursuant to the terms of its merger agreement with Histogen Inc.

May 7, 2020
·
7 min read
Business

Flexion Therapeutics Reports First-Quarter 2020 Financial Results and Recent Business Highlights

Company reported ZILRETTA® (triamcinolone acetonide extended-release injectable suspension) net sales of $20.1 million in first quarter 2020

May 7, 2020
·
15 min read